GBM News
GBM news.
NEWS June 2023

Experimental vaccine shows promise in delaying the return of aggressive brain tumor.
The vaccine, called SurVaxM, was shown to nearly double the survival time in a trial of 63 patients. Researchers now hope to confirm the findings in a larger trial.
John Wishman was diagnosed with the deadliest form of brain cancer, glioblastoma, in fall 2020.
Two and a half years later, he’s still traveling and enjoying life — a rarity for a cancer with an average survival time of just 12 to 18 months.